About Lionex

Lionex develops and supplies diagnostic and research products with a special focus on tuberculosis. We design and manufacture in Germany according to ISO quality management standards. We are committed to delivering excellence every day - and to improving human health worldwide.

Explore our portfolio Mission and legacy

Spotlight

Home

Our Mission

Tuberculosis Commitment

Longstanding Commitment to Tuberculosis

Since its founding in 1999, Lionex has been dedicated to the cause of tuberculosis. Over nearly three decades, the company has built deep expertise in mycobacterial research and diagnostics. We offer a comprehensive portfolio including IGRA tests, ELISA kits, rapid lateral flow assays, and highly purified antigens. Our solutions support early detection, research, and public health efforts against TB and related diseases globally.

Visionary Biotechnology from Germany

Visionary Biotechnology from Germany

We are an innovative biotechnology company specializing in diagnostics and research solutions for infectious diseases. State-of-the-art facilities (BSL-2) and ISO 13485-certified quality management ensure industry-leading standard for all of our in vitro diagnostic products and research reagents. Headquartered in Braunschweig, Germany, we serve customers and partners worldwide.

Partnering for Global Health Impact

Partnering for Global Health Impact

Lionex collaborates internationally with companies, research institutions, universities, hospitals, and global health organizations. Through strong partnerships and continuous innovation, Lionex delivers essential tools for diagnostics, vaccine development, and therapeutic research – driving progress and improving health outcomes.

OUR PARTNERS & CUSTOMERS

CONTACT US

Have a question or enquiry?

ORDERS: sales@lionex.de INFORMATION: info@lionex.de